Lazaros Lekakis
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL). (NCT05260957) | Lazaros Lekakis | 2022-12-14 |
Track Lazaros Lekakis automatically
Every clearance here is in the API, with alerts when new ones post.